Airsculpt Technologies, Inc.
For the period ended Dec 31, 2025. Filed Mar 31, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 31, 2026
AIRS$0.77+14.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations
| Twelve Months EndedDecember 31, | |||
|---|---|---|---|
| (in $000s, except for shares and per share figures) | 2025 | 2024 | 2023 |
| Revenue | $151,818 | $180,350 | $195,917 |
| Operating expenses: | |||
| Cost of service (exclusive of depreciation and amortization) | 61,690 | 71,149 | 73,773 |
| Selling, general and administrative(1) | 82,180 | 98,880 | 102,381 |
| Depreciation and amortization | 12,781 | 11,888 | 10,253 |
| Loss/(gain) on disposal of long-lived assets (2) | 4,575 | 16 | (212) |
| Cost related to closing location, net (3) | 2,152 | — | — |
| Total operating expenses | 163,378 | 181,933 | 186,195 |
| (Loss)/income from operations | (11,560) | (1,583) | 9,722 |
| Interest expense, net | 6,078 | 6,247 | 6,485 |
| Pre-tax net (loss)/income | (17,638) | (7,830) | 3,237 |
| Income tax (benefit)/expense | (5,971) | 188 | 7,477 |
| Net loss | $(11,667) | $(8,018) | $(4,240) |
| Loss per share of common stock | |||
| Basic | $(0.19) | $(0.14) | $(0.08) |
| Diluted | $(0.19) | $(0.14) | $(0.08) |
| Weighted average shares outstanding | |||
| Basic | 60,450,769 | 57,688,906 | 56,778,793 |
| Diluted | 60,450,769 | 57,688,906 | 56,778,793 |
| (1) | During the first quarter of fiscal year 2024, the Company recorded a cumulative reversal of stock compensation expense of $10.4 million related to reassessing the probability of achieving the performance target on certain of the Company's performance-based stock units. See Note 6 to the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for further discussion. |
| (2) | During the fiscal year ended 2025, the Company recorded a $4.5 million loss related to the impairment of a portion of the Salesforce implementation project and $0.1 million related to the corporate office PPE write-off. See Note 1 to the consolidated financial statements included in this Annual Report on Form 10-K for further discussion. |
| (3) | During the fiscal year ended 2025, the Company recorded $2.2 million in costs related to the closure of the London facility. Comprising of that amount is a $2.4 million loss on London PPE, $3.3 million rent expense from accelerated amortization, offset by a $3.2 million gain on the deconsolidation as of December 31, 2025 related to net liabilities and $0.3 million income from reclassification of CTA. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.